StockNews.com lowered shares of Utah Medical Products (NASDAQ:UTMD Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday.
Separately...
Natixis Advisors L.P. purchased a new position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD Free Report) in the 3rd quarter, according to the company in its most recent disclosure...
This is a signal that UTMD's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Quadrature Capital Ltd grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD Free Report) by 128.3% in the 3rd quarter, according to its most recent disclosure with the Securities and...
This is a signal that UTMD's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...